These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37014306)

  • 1. Real-life long-term efficacy and safety of recombinant human growth hormone therapy in children with short stature homeobox-containing deficiency.
    Bruzzi P; Vannelli S; Scarano E; Di Iorgi N; Parpagnoli M; Salerno M; Pitea M; Elisabeth Street M; Secco A; Andrea Trettene A; Wasniewska M; Corciulo N; Tornese G; Felicia Faienza M; Delvecchio M; Filomena Madeo S; Iughetti L
    Endocr Connect; 2023 Jul; 12(7):. PubMed ID: 37014306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
    Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Height of Patients with SHOX Haploinsufficiency with or without GH Therapy: A Real-World Single-Center Study.
    Dantas NCB; Funari MFA; Vasques GA; Andrade NLM; Rezende RC; Brito V; Scalco RC; Arnhold IJP; Mendonca BB; Jorge AAL
    Horm Res Paediatr; 2022; 95(3):264-274. PubMed ID: 35390795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.
    Becker M; Thomas M; Brachet C; Heinrichs C; Dotremont H; De Schepper J; Lysy P; Beckers D;
    Front Endocrinol (Lausanne); 2023; 14():1112938. PubMed ID: 37334282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
    Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
    J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
    Li J; Wu W; Liang Y; Luo XP
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].
    Jorge AA; Nishi MY; Funari MF; Souza SC; Arnhold IJ; Mendonça BB
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):765-73. PubMed ID: 18797583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency.
    Alzahrani AK; Algethami AK; Barnawi G; Meftah IA; Alshanqiti A; Al-Hashmi H; Khan MA; Felimban N
    Cureus; 2020 Mar; 12(3):e7319. PubMed ID: 32313760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short stature homeobox-containing gene duplications in 3.7% of girls with tall stature and normal karyotypes.
    Upners EN; Jensen RB; Rajpert-De Meyts E; Dunø M; Aksglaede L; Juul A
    Acta Paediatr; 2017 Oct; 106(10):1651-1657. PubMed ID: 28667773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevalence of SHOX gene deletion in children with idiopathic short stature. A multicentric study].
    Dávid A; Butz H; Halász Z; Török D; Nyirő G; Muzsnai Á; Csákváry V; Luczay A; Sallai Á; Hosszú É; Felszeghy E; Tar A; Szántó Z; Fekete GL; Kun I; Patócs A; Bertalan R
    Orv Hetil; 2017 Aug; 158(34):1351-1356. PubMed ID: 28823207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study.
    Chen J; Zhong Y; Wei H; Chen S; Su Z; Liu L; Liang L; Lu P; Chen L; Chen R; Ni S; Wang X; Li L; Wang Y; Xu X; Xiao Y; Yao H; Liu G; Jin R; Cao B; Wu D; Su C; Li W; Qin M; Li X; Luo X; Gong C
    BMC Endocr Disord; 2022 Aug; 22(1):201. PubMed ID: 35945517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of different doses of recombinant human growth hormone in the treatment of short stature in children born small for gestational age].
    Qie D; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):247-53. PubMed ID: 26975824
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.